Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Exploration of the Functional Effect of Modified Gain Precalculation on Soft Speech Intelligibility

NCT: NCT07388784 · RECRUITING

NCT IDNCT07388784
StatusRECRUITING
Start Date2026-04-20
Completion2026-05-30

Brief Summary

An exploratory investigation of gain precalculation principles in CE-labelled Sonova brand hearing instruments (e.g. Phonak hearing instruments) is intended to be conducted on hearing impaired participants. These gain precalculation principles are enabled by respective hearing instrument technologies and hearing instrument algorithms. The aim of the study is to investigate and assess strength and weaknesses of these gain precalculation principles in terms of speech intelligibility to determine their application in hearing instruments (Phase of development). Objective laboratory measurements as well as subjective ratings will be carried out. This will be a controlled, single blinded and randomized active comparator clinical evaluation which will be conducted mono centric at Sonova AG Headquarter based in Stäfa.

Frequently Asked Questions

What is Exploration of the Functional Effect of Modified Gain Precalculation on Soft Speech Intelligibility?

Exploration of the Functional Effect of Modified Gain Precalculation on Soft Speech Intelligibility is a clinical trial registered under NCT07388784. Current status: RECRUITING.

What is the status of NCT07388784?

The current status of NCT07388784 (Exploration of the Functional Effect of Modified Gain Precalculation on Soft Speech Intelligibility) is: RECRUITING.

When did Exploration of the Functional Effect of Modified Gain Precalculation on Soft Speech Intelligibility start?

Exploration of the Functional Effect of Modified Gain Precalculation on Soft Speech Intelligibility started on 2026-04-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.